Caplin Point Laboratories Hits 52-Week High of Rs 2,991: What’s Driving the Stock Today
- September 24, 2026
- Posted by: Harsh Piplani
- Category: News
Caplin Point Laboratories Share Price was Rs 2,966.50 after a 6.28% rise today, and the stock set a fresh 52-week high of Rs 2,990.60. The company’s market capitalisation stood at Rs 21,125.93 crore. The move is important because the supplied data confirms a new yearly high, but it does not establish a company-specific catalyst. For readers tracking Caplin Point Laboratories Share Price today, the key facts are the day’s price range, the close above the previous close, and the valuation and sector context that frame the move.
The stock opened at Rs 2,777.90, touched a low of Rs 2,770.00 and a high of Rs 2,990.60, then ended near the upper end of that range. Turnover stood at Rs 7.92 crore. In Univest terms, this is a clear Caplin Point Laboratories Stock News event because it combines a fresh 52-week high with a notable move in price, while the supplied data stays silent on any company-specific trigger.
Caplin Point Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,966.5 |
| Previous Close | Rs 2,791.3 |
| Today's Move | +Rs 175.2 (+6.28%) |
| Open | Rs 2,777.9 |
| High | Rs 2,990.6 |
| Low | Rs 2,770 |
| Turnover | Rs 7.92 crore |
| Market Capitalisation | Rs 21,125.93 crore |
Caplin Point Laboratories Ltd. (CAPLIPOINT) traded at Rs 2,966.5 versus the previous close of Rs 2,791.3, a rise of 6.28%. The stock opened at Rs 2,777.9, reached a high of Rs 2,990.6 and touched a low of Rs 2,770.
Caplin Point Laboratories Share Price today moved from a previous close of Rs 2,791.30 to Rs 2,966.50, a gain of Rs 175.20 or 6.28%. The day’s open was Rs 2,777.90, and the low was Rs 2,770.00, which shows that the stock traded above its opening level for most of the session and finished well above the previous close. The fresh 52-week high of Rs 2,990.60 was also the day’s high, so the move ended with the stock close to the peak of the session.
Because the current price exceeded the previous 52-week high, the breakout from that earlier level works out to 2.21% based on the supplied numbers. Turnover of Rs 7.92 crore places a factual value on the day’s traded consideration, and the close near the high keeps the Caplin Point Laboratories Share Price in focus for market watchers following 52 Week High Stocks and Stocks in News. From here, the next lens is the company’s financial profile and valuation.
Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 21,125.93 crore |
| P/E Ratio | 31.89x |
| P/B Ratio | 5.78x |
| ROE | 20.79% |
| ROCE | 24.97% |
| EPS | Rs 87.53 |
| Book Value Per Share | Rs 483.17 |
| Dividend Yield | 0.29% |
Caplin Point Laboratories Ltd. (CAPLIPOINT) fundamental metrics show P/E 31.89x, P/B 5.78x, ROE 20.79%, ROCE 24.97%. These figures provide context only and are not a buy or sell signal.
Caplin Point Laboratories Ltd. has a market capitalisation of Rs 21125.93 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.89x, P/B at 5.78x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.79% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 87.53, book value per share of Rs 483.17, dividend yield of 0.29%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.33x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 31.89x |
| Benchmark Median P/E | 32.33x |
| Benchmark Average P/E | 50.12x |
| Benchmark P/E Range | 3.48x to 762.66x |
| Company P/B Ratio | 5.78x |
| Benchmark Median P/B | 2.95x |
| Company ROE | 20.79% |
| Benchmark Median ROE | 11.69% |
| Company ROCE | 24.97% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 21,125.93 crore |
| Benchmark Median Market Cap | Rs 745.38 crore |
Caplin Point Laboratories Ltd. (CAPLIPOINT) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.89x, which is below the benchmark median of 32.33x, a difference of -1.36%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROE of 20.79%, which is above the benchmark median of 11.69%, a difference of +77.84%. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROCE of 24.97%, which is above the benchmark median of 13.32%, a difference of +87.46%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Shilpa Medicare Ltd. | SHILPAMED | 20,207.51 | 68.22 | 7.55 | 9.82 | 11.43 |
| Granules India Ltd. | GRANULES | 23,581.82 | 35.42 | 4.79 | 14.13 | 15.74 |
| Pfizer Ltd. | PFIZER | 18,274.85 | 25 | 4.17 | 17.16 | 23.39 |
| Eris Lifesciences Ltd. | ERIS | 17,675.99 | 27.36 | 4.37 | 19.23 | 14.47 |
| Suven Pharmaceuticals Ltd. | COHANCE | 17,308.7 | 166.23 | 4.59 | 4.02 | 6.12 |
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.89x compared with the displayed peer median of 35.42x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.79% compares with a peer median of 14.13% across the companies shown in the table. ROCE stood at 24.97% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a market capitalisation of Rs 21,125.93 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Caplin Point Laboratories
- Caplin Point Laboratories Share Price closed at Rs 2,966.50 after rising 6.28% on the day.
- The stock set a fresh 52-week high at Rs 2,990.60, which is also the day’s high.
- Caplin Point Laboratories Market Cap stood at Rs 21,125.93 crore.
- P/E was 31.89, P/B was 5.78, ROE was 20.79% and ROCE was 24.97%.
- Revenue moved from Rs 5,102.2 crore in Jun-25 to Rs 6,103.6 crore in Jun-26, while net profit increased from Rs 1,528 crore to Rs 1,769.1 crore.
About Caplin Point Laboratories
Caplin Point Laboratories Ltd. is classified in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not provide a longer business description, product list or segment breakdown, so the company profile here stays limited to the verified sector and industry classification. For readers using Caplin Point Laboratories Share Price pages on Univest, that classification is useful because it anchors the stock within the same industry benchmark used throughout this article. This keeps Caplin Point Laboratories Stock News and Caplin Point Laboratories Share Price today anchored in a factual company context.
Track Caplin Point Laboratories Share Price on Univest
Use Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Univest tracks Caplin Point Laboratories Share Price alongside live price action, 52-week levels, fundamental ratios, shareholding pattern, sector comparisons and market insights. Readers can follow Caplin Point Laboratories Share Price today, Caplin Point Laboratories Latest News and Caplin Point Laboratories Share Price Update in one place without relying on scattered market references. Univest also presents Caplin Point Laboratories Share Price in a format designed for quick stock analysis and factual monitoring.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Caplin Point Laboratories Share Price move today?
Ans. Caplin Point Laboratories Share Price rose 6.28% to Rs 2,966.50 and set a fresh 52-week high of Rs 2,990.60. The supplied data confirms the price event, but it does not establish a company-specific catalyst.
What is the fresh 52-week high for Caplin Point Laboratories?
Ans. The fresh 52-week high is Rs 2,990.60. That was also the day’s high, making Caplin Point Laboratories Share Price a clear one-year high event in the supplied market data. The stock moved 6.28% during the session.
What was Caplin Point Laboratories Share Price today?
Ans. Caplin Point Laboratories Share Price closed at Rs 2,966.50. It was above the previous close of Rs 2,791.30 and ended close to the day’s top end after touching Rs 2,990.60.
What is Caplin Point Laboratories Market Cap?
Ans. Caplin Point Laboratories Market Cap is Rs 21,125.93 crore. That places the company above the industry benchmark median market cap of Rs 745.38 crore in the supplied same-industry snapshot. The company operates in the Healthcare sector.
How does Caplin Point Laboratories compare on valuation?
Ans. Caplin Point Laboratories trades at a P/E of 31.89 and P/B of 5.78. Its P/E is slightly below the industry median, while its P/B is above the industry median and average.
What do the profitability metrics show for Caplin Point Laboratories?
Ans. The company reports ROE of 20.79% and ROCE of 24.97%. Both are above the industry medians in the supplied benchmark, which gives useful context for Caplin Point Laboratories Stock Analysis.
What are Caplin Point Laboratories EPS and book value?
Ans. EPS is Rs 87.53 and book value per share is Rs 483.17. EPS shows earnings attributable to each share, while book value reflects the accounting net worth behind each share in Caplin Point Laboratories Share Price analysis.
Does Caplin Point Laboratories pay a dividend?
Ans. Yes, the supplied dividend yield is 0.29%. Dividend yield is a historical or current payout measure, so it should be read alongside Caplin Point Laboratories Share Price, valuation and profitability rather than in isolation.
